Steven K. Galson - Jun 12, 2025 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/16/2025, 04:19 PM
Previous filing
Jun 14, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galson Steven K Director 4505 EMPEROR BLVD., SUITE 200, DURHAM /s/ Alane P. Barnes, by power of attorney 2025-06-16 0001495328

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $0 +12.5K +100.07% $0.00 25K Jun 12, 2025 Direct F1
holding BCRX Common Stock 45.9K Jun 12, 2025 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Automatic Stock Option Grant Award $0 +27.2K $0.00 27.2K Jun 12, 2025 Common Stock 27.2K $10.40 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
F2 On July 16, 2024 and October 2, 2024, the Reporting Person transferred 12,600 and 11,340 shares, respectively, to a living trust for no consideration. The Reporting Person is an indirect beneficial owner of the shares held by the trust.
F3 Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney